Virbac appoints Eline Madelpuech as non-voting board member

Bitget2026/09/28 12:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Virbac appointed Eline Madelpuech as a non-voting board member on Sept. 17, giving her an advisory role in meetings.
Madelpuech holds a medical degree from the University of Liège, an INSEAD MBA, worked in strategy and business development at a human healthcare laboratory.
Independent director Olivier Charmeil joined the Audit Committee, adding to his role on the Appointments and Compensation Committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virbac SA published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Yardeni Research has lowered its year-end S&P 500 target to 7,900 points and reduced its valuation target to 18.6 times, mainly due to risk-off sentiment suppressing valuations rather than deteriorating earnings. Despite facing risk aversion and policy risks, Yardeni remains optimistic about corporate earnings and the medium-to-long-term economy, viewing pullbacks as buying opportunities.

华尔街见闻•2026/10/15 13:26